Phase II/III clinical results of IL-15R[alpha]Fc superagonist N-803 with BCG in BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) carcinoma in situ (CIS) patients.

被引：19

作者：

Chamie, Karim ^{[1
]}

Chang, Sam ^{[2
]}

Gonzalgo, Mark L. ^{[3
]}

Kramolowsky, Eugene, V ^{[4
]}

Sexton, Wade J. ^{[5
]}

Reddy, Sandeep K. ^{[6
]}

Bhar, Paul ^{[7
]}

Garner, Chad ^{[8
]}

Soon-Shiong, Patrick ^{[9
]}

机构：

[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Inst Urol Oncol IUO, Los Angeles, CA 90095 USA

[2] Vanderbilt Univ, Sch Med, Dept Urol Surg, Nashville, TN 37212 USA

[3] Univ Miami, Miller Sch Med, Miami, FL 33136 USA

[4] Virginia Urol Ctr PC, Richmond, VA USA

[5] H Lee Moffitt Canc Ctr & Res Inst, Dept Genitourinary Oncol, Tampa, FL USA

[6] NantOmics LLC, Santa Cruz, CA USA

[7] ImmunityBio Inc, Morrisville, NC USA

[8] ImmunityBio, Culver City, CA USA

[9] NantKwest Inc, Culver City, CA USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 06期

关键词：

D O I：

10.1200/JCO.2021.39.6_suppl.510

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

510

引用

页数：3

共 50 条

[1] Preliminary phase 2 clinical results of IL-15RαFc superagonist N-803 with BCG in BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) patients.
Chamie, Karim
Lee, John H.
Rock, Amy
Rhode, Peter R.
Soon-Shiong, Patrick
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[2] PHASE 2/3 CLINICAL RESULTS OF IL-15RAFC SUPERAGONIST N-803 WITH BCG IN BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) CARCINOMA IN-SITU (CIS) PATIENTS.
Chamie, Karim
Chang, Sam
Gonzalgo, Mark
Kramolowski, Eugene
Reddy, Sandeep
Soon-Shiong, Patrick
Garner, Chad
JOURNAL OF UROLOGY, 2021, 206 : E120 - E121
[3] Final clinical results of pivotal trial of IL-15RαFc superagonist N-803 with BCG in BCG-unresponsive CIS and papillary nonmuscle-invasive bladder cancer (NMIBC).
Chamie, Karim
Chang, Sam S.
Gonzalgo, Mark
Kramolowsky, Eugene V.
Sexton, Wade J.
Bhar, Paul
Reddy, Sandeep K.
Soon-Shiong, Patrick
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[4] FINAL CLINICAL RESULTS OF PIVOTAL TRIAL OF IL-15RAFC SUPERAGONIST N-803 WITH BCG IN BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) CIS AND PAPILLARY COHORTS
Chang, Sam
Chamie, Karim
Hidalgo, Mark
Kramolowsky, Eugene
Sexton, Wade
Reddy, Sandeep
Soon-Shiong, Patrick
JOURNAL OF UROLOGY, 2022, 207 (05): : E1047 - E1047
[5] Positive efficacy and safety phase 3 results in both CIS and papillary cohorts BCG-unresponsive nonmuscle invasive bladder cancer (NMIBC) after IL-15RαFc superagonist N-803 (Anktiva) and BCG infusion.
Chang, Sam S.
Chamie, Karim
Gonzalgo, Mark L.
Kramolowsky, Eugene V.
Sexton, Wade J.
Reddy, Sandeep K.
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
[6] Quality of life in QUILT 3.032 study: Patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) receiving IL-15RaFc superagonist N-803 plus BCG.
Chamie, Karim
Chang, Sam S.
Kramolowsky, Eugene V.
Gonzalgo, Mark L.
Lechpammer, Stanislav
Reddy, Sandeep K.
Soon-Shiong, Patrick
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
[7] AN INTERIM ANALYSIS OF A PHASE II CLINICAL STUDY OF INTRAVESICAL PHOTO DYNAMIC THERAPY IN PATIENTS WITH BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) CARCINOMA IN-SITU (CIS)
Kulkarni, Girish
Richards, Kyle
Black, Peter C.
Rendon, Ricardo
Chin, Joseph
Shore, Neal
Jayram, Gautam
Kramolowsky, Eugene
Saltzstein, Daniel
Agarwal, Piyush
Belkoff, Laurence
O'Donnell, Michael
Kamat, Ashish M.
Zlotta, Alexandre
Jewett, Michael A. S.
Lamm, Donald
DeGruttola, Victor
Mandel, Arkady
Dumoulin-White, Roger J.
Kassouf, Wassim
JOURNAL OF UROLOGY, 2023, 209 : E871 - E871
[8] PHASE 3 RESULTS OF VICINIUM IN BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER
Shore, Neal
O'Donnell, Michael
Keane, Thomas
Jewett, Michael A. S.
Kulkarni, Girish S.
Dickstein, Rian
Wolk, Fred
Dunshee, Curtis
Belkoff, Laurence
Dillon, Rachelle L.
Cizeau, Jeannick
Kassouf, Wassim
JOURNAL OF UROLOGY, 2020, 203 : E72 - E72
[9] Re: IL-15 Superagonist NAI in BCG-Unresponsive Non-muscle-invasive Bladder Cancer
Suderman, Jonathan
St-Laurent, Marie-Pier
Black, Peter C.
EUROPEAN UROLOGY, 2023, 83 (06) : 581 - 581
[10] A multicenter clinical trial of intravesical BCG in combination with ALT-803 in patients with BCG-unresponsive non-muscle invasive bladder cancer.
Chamie, Karim
Salmasi, Amirali
Rosser, Charles Joel
Rock, Amy
Ferguson, Lydia
Wong, Hing C.
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)

← 1 2 3 4 5 →